Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 3/20 | 0.36 |
| ▸ | NOS2 | P35228 | 3/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | INMT | O95050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809866 | 0.92 | NOS3 (0.30) | NOS1NOS2NOS3 | |
| SCHEMBL15437769 | 0.79 | NOS1 (0.53) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL810036 | 0.76 | NOS1 (0.35) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL16591592 | 0.75 | NOS3 (0.37) | NOS1NOS2NOS3 | |
| SCHEMBL16591593 | 0.74 | NOS3 (0.37) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL8147596 | 0.72 | CHRNB2 (0.40) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL809794 | 0.72 | CHRNB2 (0.40) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL12587871 | 0.72 | NOS3 (0.41) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL17215357 | 0.72 | CHRNB2 (0.40) | NOS1NOS2NOS3USP2INMT | |
| SCHEMBL809756 | 0.72 | CHRNB2 (0.40) | NOS1NOS2NOS3USP2INMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163120-B2 | Adhesive for production of IC card, process for producing IC card, and IC card | EMULSION TECHNOLOGY CO., LTD. (JP) | 2012-04-24 | — | — | US | claimed |
| EP-4691523-A1 | MEDICAL INSTRUMENT, TREATMENT SOLUTION, AND METHOD FOR MANUFACTURING MEDICAL INSTRUMENT | JMS Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | NITTO KASEI CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-4174053-B1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-19 | — | — | EP | disclosed |
| EP-3686255-B1 | COATING COMPOSITION, COATING MATERIAL, CURED FILM, ARTICLE INCLUDING CURED FILM, AND PRODUCTION METHOD FOR ARTICLE INCLUDING CURED FILM | NATOCO CO LTD (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-3725814-B1 | PHOTOCURABLE COMPOSITION AND PRODUCT | CEMEDINE CO LTD (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024204412-A1 | MEDICAL INSTRUMENT, TREATMENT SOLUTION, AND METHOD FOR MANUFACTURING MEDICAL INSTRUMENT | 株式会社ジェイ・エム・エス | 2024-10-03 | — | — | WO | disclosed |
| CN-115516041-B | Curing catalyst for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | 日东化成株式会社 | 2024-06-28 | — | — | CN | disclosed |
| US-11827818-B2 | Photocurable composition and product | CEMEDINE CO., LTD. (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20100216925-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| US-20100171414-A1 | SEALING AGENT FOR OPTICAL SEMICONDUCTOR ELEMENT, AND OPTICAL SEMICONDUCTOR ELEMENT | SEKISUI CHEMICAL CO., LTD. (JP) | 2010-07-08 | — | — | US | disclosed |
| US-7704939-B2 | Surfactant | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-27 | — | — | US | disclosed |
| EP-2177571-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2010-04-21 | — | — | EP | disclosed |
| EP-2159242-A1 | SEALING AGENT FOR OPTICAL SEMICONDUCTOR ELEMENT, AND OPTICAL SEMICONDUCTOR ELEMENT | Sekisui Chemical Co., Ltd. (JP) | 2010-03-03 | — | — | EP | disclosed |
| US-20100009105-A1 | ACRYLIC RUBBER COMPOSITION AND VULCANIZED PRODUCT | DENKI KAGAKU KIGYO KABUSHIKI KAISHA (JP) | 2010-01-14 | — | — | US | disclosed |
| EP-2098567-A1 | ACRYLIC RUBBER COMPOSITION AND VULCANIZATE THEREOF | Denki Kagaku Kogyo Kabushiki Kaisha (JP) | 2009-09-09 | — | — | EP | disclosed |
| EP-1990370-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2008-11-12 | — | — | EP | disclosed |
| US-20080102268-A1 | Adhesive for Production of Ic Card, Process for Producing Ic Card, and Ic Card | EMULSION TECHNOLOGY CO., LTD. (JP) | 2008-05-01 | — | — | US | disclosed |
| US-20070167343-A1 | neutralized salt including alkylbenzenesulphonates (toluenesulfonic acid guanidine salt, toluenesulfonic acid DBU salt, toluenesulfonic acid DBN salt) for cleaning electonics | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | KDM2B, SETDB1, ASH2L | NOS1 25/4885NOS2 10/4885NOS3 190/4885 |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | NOS1 25/4885NOS2 10/4885NOS3 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.